Nymox Pharmaceutical Corp (NASDAQ:NYMX)

CAPS Rating: 1 out of 5

A biopharmaceutical company with three proprietary products on the market and a R&D of drug & diagnostic products in development for the treatment of enlarged prostate, Alzheimer's disease contamination of food and drink products and bacterial infections.

Recs

0
Player Avatar pcolajoe (68.68) Submitted: 8/16/2010 11:55:57 AM : Outperform Start Price: $4.41 NYMX Score: +50.93

Steady growth.

Featured Broker Partners


Advertisement